CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.
logo
Font
Back color
Site version
logo
  • In all sections
  • In medicines
  • In research
  • In news
  • Education hub
Often searched for
31 January 2023

"Darnitsa" became one of the winners of the "Responsible Country" project by MMR and delo ua

"Darnitsa" won in the nomination "Cooperation between business and the state" in the special project "Responsible country" of MMR and delo ua

In cooperation with the Ministry of Health of Ukraine and the National Security and Defence Council of Ukraine, in April 2022, "Darnitsa" registered a medicine to protect the population from radiation and put it into production in just 12 days. The company provided 6.5 million doses of the drug free of charge for the needs of the Ministry of Health of Ukraine.

The year 2022 became a period of active support for the Armed Forces and those who suffered because of the war. Today, "Darnitsa" continues to help the country.